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Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles 
as a drug delivery system 
ABSTRACT 
Background: Iron oxide nanoparticles are of considerable interest because of their use in 
magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and 
treatment of cancer. The specific morphology of nanoparticles confers an ability to load, 
carry, and release different types of drugs. Methods and results: We synthesized super 
paramagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. 
Fourier transform infrared spectra confirmed that these Fe3O4 nanoparticles could be 
successfully coated with active drug, and thermogravimet-ric and differential 
thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles 
coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The 
synthesized Fe3O4 nanoparticles and the FCMP nanocomposite were generally spherical, 
with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine 
from the FCMP nanocomposite was found to be sustained and governed by pseudo-second 
order kinetics. In order to improve drug loading and release behavior, we prepared a novel 
nanocomposite (FCMP-D), ie, Fe3O4 nanoparticles containing the same amounts of chitosan 
and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did 
not demonstrate "burst release" and the maximum percentage release of 6-mercaptopurine 
from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 
2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By 
MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse 
fibroblast cell line. Conclusion: Iron oxide coated with chitosan containing 6-mercaptopurine 
prepared using a coprecipitation method has the potential to be used as a controlled-release 
formulation. These nanoparticles may serve as an alternative drug delivery system for the 
treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue. 
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